Sinotherapeutics Inc. A - Asset Resilience Ratio

Latest as of June 2025: 37.00%

Sinotherapeutics Inc. A (688247) has an Asset Resilience Ratio of 37.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 688247 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥534.11 Million

≈ $78.16 Million USD Cash + Short-term Investments

Total Assets

CN¥1.44 Billion

≈ $211.22 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2024)

This chart shows how Sinotherapeutics Inc. A's Asset Resilience Ratio has changed over time. See Sinotherapeutics Inc. A (688247) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sinotherapeutics Inc. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinotherapeutics Inc. A (688247) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥534.11 Million	37.0%
Total Liquid Assets	CN¥534.11 Million	37.00%

Asset Resilience Insights

Very High Liquidity: Sinotherapeutics Inc. A maintains exceptional liquid asset reserves at 37.00% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Sinotherapeutics Inc. A Industry Peers by Asset Resilience Ratio

Compare Sinotherapeutics Inc. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.44%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	20.24%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%

Annual Asset Resilience Ratio for Sinotherapeutics Inc. A (2024–2024)

The table below shows the annual Asset Resilience Ratio data for Sinotherapeutics Inc. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	34.94%	CN¥507.74 Million ≈ $74.30 Million	CN¥1.45 Billion ≈ $212.66 Million	--

pp = percentage points

About Sinotherapeutics Inc. A

SHG:688247 China Drug Manufacturers - Specialty & Generic

Market Cap

$636.84 Million

CN¥4.35 Billion CNY

Market Cap Rank

#11347 Global

#3410 in China

Share Price

CN¥9.60

Change (1 day)

+3.23%

52-Week Range

CN¥8.87 - CN¥13.01

All Time High

CN¥25.98